论文部分内容阅读
慢性粒细胞白血病(CML),用一般支持治疗,中数存活可达31个月。自1952年马利兰的应用及1962年羟基脲的出现,半个世
Chronic myeloid leukemia (CML), with general supportive care, median survival up to 31 months. Since 1952 Maryland’s application and the emergence of hydroxyurea in 1962, half a lifetime